Skip to main content
. 2019 Nov 6;34(3):e23096. doi: 10.1002/jcla.23096

Figure 1.

Figure 1

Measurement of miR‐223 expression by using Quantitative reverse transcription‐polymerase chain reaction. MiR‐223 expression was significantly decreased in acute myeloid leukemia cases compared with normal controls (P < .05). MiR‐223 levels in favorable cytogenetic risk group were frequently higher those in intermediate/unfavorable cytogenetic risk groups (P < .05)